4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-023736
Director sold 10,000 shares at $23.88 ($238,801)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Welgus Howard G. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-01 | Sale : show line 1 in the form 10b5-1 | −10,000 | $23.88 | $238,801 | 39,744 | D |
| Open-market sales · 10,000 sh · avg $23.88 · $238,801 | ||||||
Loading xslF345X06/wk-form4_1775252777.xml…